Measurement of the Folate Receptor in Stored Plasma From Patients With Ovarian Cancer
N/A
N/A
Female
Ovarian Cancer
Trial Information
Measurement of the Folate Receptor in Stored Plasma From Patients With Ovarian Cancer
FR may be released from the cancer cells in the blood. We have developed a method in the
laboratory which has been able to measure the FR obtained from cancer cells in culture which
has been added into blood. We would like to study if this method is able to measure the FR
in stored plasma samples obtained from patients with ovarian cancer, so that it may be
developed as a method for selecting patients for FR-target treatments such as BGC 945.
Inclusion Criteria:
- Patients with ovarian cancer who have given informed consent to have blood collected
for the plasma bank in the 'Pharmacogenetics and proteomics studies in patients
receiving novel anticaner agents' study.
Exclusion Criteria:
- Patients who have withdrawn consent form their blood stored within the
'Pharmacogenetics and proteomics studies in patients receiving novel anticancer
agents' study to be used for research.
Type of Study:
Observational
Study Design:
N/A
Outcome Measure:
To measure the levels of soluble folate receptor in stored plasma obtained from patients with ovarian cancer
Safety Issue:
No
Authority:
United Kingdom: National Health Service
Study ID:
CCR3029
NCT ID:
NCT00787514
Start Date:
July 2008
Completion Date:
February 2011
Related Keywords:
- Ovarian Cancer
- ovarian cancer, folate receptor, plasma
- Ovarian Neoplasms
Name | Location |
|---|
